Attentional Focus Training on Visuomotor Control in Older Adults
NCT ID: NCT07085364
Last Updated: 2025-07-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
16 participants
INTERVENTIONAL
2025-08-01
2026-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Brain Stimulation Effects on Orientation and Mobility Skills in Adults With Vision Impairment
NCT07341763
Training Oculo-motor Control to Improve Vision When Using a Preferred Retinal Locus
NCT05637385
Oculomotor Training Improves Reading Eye Movement
NCT02981875
Study of Visual-spatial Attention by Eye Tracking as a Function of Central or Peripheral Visual Impairment
NCT03505398
Effect of Oculomotor Therapy in Individuals With Convergence Insufficiency
NCT07036263
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
EXT
External focus manipulation
Attentional focus
Every training session will include the following activities for both groups: a 5-minute warm-up; a 30-minute walking training; and a 5-minute cool-down. The walking training will be conducted within a level-ground walking field. Participants will be instructed to look at and step on specific markers/labels that will be attached along the walking paths.
CON
Traditional manipulation
Control
Every training session will include the following activities for both groups: a 5-minute warm-up; a 30-minute walking training; and a 5-minute cool-down. The walking training will be conducted within a level-ground walking field. No markers/labels will be attached and no relevant instructions will be provided apart from the general instruction.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Attentional focus
Every training session will include the following activities for both groups: a 5-minute warm-up; a 30-minute walking training; and a 5-minute cool-down. The walking training will be conducted within a level-ground walking field. Participants will be instructed to look at and step on specific markers/labels that will be attached along the walking paths.
Control
Every training session will include the following activities for both groups: a 5-minute warm-up; a 30-minute walking training; and a 5-minute cool-down. The walking training will be conducted within a level-ground walking field. No markers/labels will be attached and no relevant instructions will be provided apart from the general instruction.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* able to walk independently indoor for at least 40 metres
* static visual acuity score 20/40 or above
* scoring 22/30 or above in the Montreal Cognitive Assessment Hong Kong version
* without any history of untreated major neurological, vestibular or musculoskeletal deficits (e.g., stroke or Parkinson's disease)
* without any unstable medical condition that can compromise safety during the experiment
* scoring less than 24/28 in the Tinetti Balance Assessment Tool or scoring 50/56 or below in the Berg Balance Scale
Exclusion Criteria
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Hong Kong Polytechnic University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HSEARS20250107004
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.